Skip to main content
Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
0.860
+0.010 (1.19%)
At close: Dec 20, 2024, 4:00 PM
0.880
+0.020 (2.31%)
After-hours: Dec 20, 2024, 7:11 PM EST

Jin Medical International Revenue

Jin Medical International had revenue of $10.56M in the half year ending March 31, 2024, with 11.51% growth. This brings the company's revenue in the last twelve months to $20.13M, up 0.75% year-over-year. In the fiscal year ending September 30, 2023, Jin Medical International had annual revenue of $19.82M with 3.29% growth.

Revenue (ttm)
$20.13M
Revenue Growth
+0.75%
P/S Ratio
6.65
Revenue / Employee
$82,144
Employees
245
Market Cap
134.63M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202319.82M630.92K3.29%
Sep 30, 202219.19M-1.57M-7.58%
Sep 30, 202120.76M4.57M28.22%
Sep 30, 202016.19M-4.17M-20.49%
Sep 30, 201920.37M-545.02K-2.61%
Sep 30, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nevro 419.15M
Puma Biotechnology 243.57M
Akoya Biosciences 86.82M
Compugen 59.85M
Protalix BioTherapeutics 45.67M
Revenue Rankings

ZJYL News

More News